Centrex Retains Crescent Fund, Inc.Business Editors, Health/Medical Writers Centrex, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CNEX) today announced that Crescent Fund, Inc., a private equity firm with offices in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , Dallas and Los Angeles has been retained to provide corporate capitalization and investor relations Investor relations The process by which the corporation communicates with its investors. consulting services. Crescent Fund is a private equity firm that invests on a principal basis and acts in an agency capacity to procure capital for emerging small-cap companies. Crescent will identify institutional funding sources and will complement the investor relations activities of Centrex. "We are pleased to be associated with Centrex, a company that is in the process of developing a technology to provide for the immediate detection of agents that could be used in biological warfare biological warfare, employment in war of microorganisms to injure or destroy people, animals, or crops; also called germ or bacteriological warfare. Limited attempts have been made in the past to spread disease among the enemy; e.g. against the United States," said Jeffery S. Stone, Managing Director. Centrex owns the exclusive worldwide license to develop, manufacture and market a system for detecting microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. contamination in air, food and water. The detection system is designed to be adaptable and easily tailored to detect a variety of bacterial or viral organisms by recognizing the unique DNA fingerprint of the organism. Since the September 11th attacks On September 11, 2001, in the deadliest case of domestic Terrorism in the history of the United States, a group of 19 terrorists hijacked four U.S. airliners for use as missiles against targets in New York City and Washington, D.C. and the subsequent bioterrorism attacks through the U.S. mail, the Company has expanded its mission to include the development of technology for the rapid detection of potential bioterrorism agents. The organisms being considered for detection by the proposed device include all those named in the validated threat list published by the Defense Intelligence Agency Noun 1. Defense Intelligence Agency - an intelligence agency of the United States in the Department of Defense; is responsible for providing intelligence in support of military planning and operations and weapons acquisition DIA , in addition to several other potential biowarfare agents. The proposed device is a simultaneous multi-channel detection system that is compact, fully automated and capable of monitoring the presence of biological agents in air, food and water. For more information, visit the Centrex website at www.centrexcorporation.com or call Investor Relations at 585/216-2072. To contact Crescent Fund, e-mail crescentfund@yahoo.com or call Jeffery Stone at 212/509-3060. This press release contains some forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in the Company's SEC filings. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion